Why the study?
Although obesity is curable and weight loss can restore heart phenotype, it is unclear whether after-effects of obesity persist after weight loss.
Does calorie restriction-induced weight loss reverse the structural and proteomic manifestations of obesity cardiomyopathy in a rat model?
Does calorie restriction-induced weight loss reverse the structural and proteomic manifestations of obesity cardiomyopathy in a rat model?
In a rat model of obesity cardiomyopathy, weight loss normalizes heart size but fails to completely reverse cardiac fibrosis and proteomic alterations.
Persistent fibrosis after weight loss in obese rats; leaves open whether adjunctive therapies are needed in human obesity cardiomyopathy.
Obesity cardiomyopathy increases the risk of heart failure and death. Obesity is curable, leading to the restoration of the heart phenotype, but it is not clear if there are any after-effects of obesity present after weight loss. We characterize the proteomic landscape of obesity cardiomyopathy with an evaluation of whether the cardiac phenotype is still shaped after weight loss. Cardiomyopathy was validated by cardiac hypertrophy, fibrosis, oversized myocytes, and mTOR upregulation in a rat model of cafeteria diet-induced developmental obesity. By global proteomic techniques (LC-MS/MS) a plethora of molecular changes was observed in the heart and circulation of obese animals, suggesting abnormal utilization of metabolic substrates. This was confirmed by increased levels of cardiac ACSL-1, a key enzyme for fatty acid degradation and decreased GLUT-1, a glucose transporter in obese rats. Calorie restriction and weight loss led to the normalization of the heart's size, but fibrosis was still excessive. The proteomic compositions of cardiac tissue and plasma were different after weight loss as compared to control. In addition to morphological consequences, obesity cardiomyopathy involves many proteomic changes. Weight loss provides for a partial repair of the heart's architecture, but the trace of fibrotic deposition and proteomic alterations may occur.
No takes yet. Share an insight, caveat, or question.
Liśkiewicz et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: